The tuberculous meningitis landscape is experiencing unprecedented transformation as pharmaceutical innovation converges with urgent clinical needs. This critical form of central nervous system tuberculosis continues to challenge healthcare providers globally, creating substantial market opportunities for companies capable of delivering breakthrough therapeutic solutions and...